The menopausal transition may represent an inflection point for worsening of multiple sclerosis in women, according to study findings.

The Swiss biopharmaceutical company Light Chain Bioscience has developed a novel and unique class of human, bispecific antibodies dubbed κλ bodies, so-called because they combine a κ light ...

One of the main reasons͏ for LCAI’s chance is its special skill to merge smart thinking with block chain tech. This mix makes LCAI different from many other coins in the market. While some ...

Utilizing Quanterix’s Simoa® platform, this neurofilament light chain assay employs digital immunoassay technology to detect and quantify biomarkers at extremely low levels. The advantages of ...